肿瘤基因检测

Search documents
艾德生物收盘上涨2.39%,滚动市盈率29.79倍,总市值83.75亿元
Sou Hu Cai Jing· 2025-06-09 09:54
序号股票简称PE(TTM)PE(静)市净率总市值(元)66艾德生物29.7932.864.3683.75亿行业平均 50.6449.074.68109.10亿行业中值37.0537.632.5050.67亿1天益医疗-1817.92-3113.901.9423.17亿2澳华内 镜-726.69364.475.8276.58亿3诺唯赞-431.93-510.862.3792.43亿4爱朋医疗-431.66327.945.2035.42亿5博晖 创新-337.40535.413.6049.50亿6硕世生物-147.79-2159.571.3243.23亿7奥精医疗-142.33-208.621.8826.42亿 8睿昂基因-105.65-86.741.5013.67亿9康泰医学-87.85-74.223.1357.82亿10中红医疗-74.13-59.130.9451.52亿 11热景生物-67.89-78.225.01149.40亿 来源:金融界 厦门艾德生物医药科技股份有限公司的主营业务是肿瘤基因检测试剂、软件及配套仪器,并提供检测服 务及药物临床研究服务。公司的主要产品是检测试剂、检测服务、药物临床研究服务 ...
金域医学:智能体应用为超1.3万家基层医疗机构提供普惠服务
Zheng Quan Shi Bao Wang· 2025-05-21 13:19
Core Insights - The company, Kingmed Medical, released its 2024 Sustainable Development Report, marking its first comprehensive disclosure based on the four-element framework for sustainable development reports for listed companies [1] - Kingmed Medical integrates sustainable development goals with its operations, focusing on medical testing technology innovation and digital tools to provide precise medical testing services throughout the lifecycle [1] Group 1: Sustainable Development and Innovation - Kingmed Medical has launched the intelligent application "Xiaoyu Medical," which has served over 13,000 grassroots medical institutions, enhancing the quality of medical services and addressing resource shortages in these areas [2] - The company has developed the first large model in the medical testing industry, "Yujian Yiyan," and the intelligent application "Xiaoyu Medical," which offers project consultation, report interpretation, knowledge Q&A, and medication guidance [2] - The company has provided medical testing cooperation and smart medical testing services to 128 tightly-knit county medical communities [3] Group 2: Affordable Healthcare Initiatives - Kingmed Medical's affordable product series has served over 2 million people, aiming to lower the barriers to medical testing and make high-end medical technology accessible to a broader population [4] - The "Hui Min 3000" tumor gene testing system covers 18 common solid tumors and is priced under 3,000 yuan, helping 30,000 patients achieve precise diagnoses [4] Group 3: Community Support and Rural Revitalization - Kingmed Medical collaborates with the Guangzhou Kingmed Charity Foundation to engage in health assistance, industry support, education, and charity in 140 poverty-stricken counties, including 31 key rural revitalization counties [5] - The company has established 182 medical laboratories in 15 provinces and regions, enhancing medical testing and pathological diagnosis services in these areas [5] - Kingmed Medical has conducted over 220 public welfare activities, covering various diseases and reaching 29 provinces and regions across the country [6]
医生推荐一名患者获200元好处费 肿瘤基因检测灰色内幕曝光
Zhong Guo Jing Ying Bao· 2025-05-14 09:57
(行政处罚信息。上海市市场监管局官网/截图) 相关通知称,近期公司面临增资,主要经营账户却被个别股东恶意冻结,业务收入断崖式下滑,导致公 司日常运营面临巨大挑战。基于此,公司经过慎重评估,不得不作出停工停产的决定。停工停产涉及人 员为至本医疗集团及分子公司、外包公司及全体员工。 至本医学允许王某某将前述费用,以餐饮费、打车费名义进行报销。经审计,通过上述方式,至本医学 最终实际获得基因检测业务订单309笔,涉案销售金额为477.62万元,违法所得共计229.2万元。 上海市普陀区市场监管局认为,当事人至本医学上述行为,违反了《中华人民共和国反不正当竞争法》 第七条第一款第(三)项之规定,构成不正当竞争行为。 2025年1月13日,上海市普陀区市场监管局对至本医学没收违法所得229.2万元,罚款100万元,合计罚 没金额为329.2万元。 上海市普陀区市场监管局在科普文章中称,涉案企业企图通过虚假报销、隐匿资金流向等手段掩盖对医 生行贿的违法事实。案件始于患者举报——某医院医生与上海某医学检验所员工王某某的异常往来。 执法部门突破重重阻碍,通过逐一梳理涉案订单资金流向、核实销售人员的实际工作内容、劳务关系 等, ...